High-dose osimertinib for CNS progression in EGFR+ non-small cell lung cancer (NSCLC): A multi-institutional experience Meeting Abstract
| Authors: | Piper-Vallillo, A.; Rotow, J. K.; Aredo, J. V.; Shaverdashvili, K.; Luo, J.; Carlisle, J. W.; Husain, H.; Muzikansky, A.; Heist, R. S.; Rangachari, D.; Ramalingam, S. S.; Wakelee, H. A.; Yu, H. A.; Sequist, L. V.; Bauml, J.; Neal, J. W.; Piotrowska, Z. |
| Abstract Title: | High-dose osimertinib for CNS progression in EGFR+ non-small cell lung cancer (NSCLC): A multi-institutional experience |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368303485 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.9586 |
| Notes: | Meeting Abstract: 9586 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
